NCT06714617
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06714617
Title Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SystImmune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
SCRI-Denver HealthOne Denver Colorado 37203 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary Florida 32746 United States Details
Hematology Oncology Associates of the Treasure Cost Port Saint Lucie Florida 34952 United States Details
SCRI-Florida Cancer Center Specialists Sarasota Sarasota Florida 34236 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
SCRI-Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
SCRI-Oncology Partners Nashville Tennessee 37203 United States Details
NEXT Oncology Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field